Covered recipient · General Payments record
SARAH YOHO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$901.99
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $438.72 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $153.10 | 6 |
| Amgen Inc. | $139.56 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.46 | 2 |
| GENZYME CORPORATION | $38.67 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.41 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.68 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.06 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108450638 | CMS |
| ABBVIE INC. | $33.41 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108450640 | CMS |
| ABBVIE INC. | $20.42 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108450642 | CMS |
| ABBVIE INC. | $11.79 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108450644 | CMS |
| ABBVIE INC. | $31.42 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108450646 | CMS |
| ABBVIE INC. | $25.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108450648 | CMS |
| Amgen Inc. | $8.29 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723778 | CMS |
| Amgen Inc. | $73.94 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723780 | CMS |
| Amgen Inc. | $4.45 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723782 | CMS |
| Amgen Inc. | $23.32 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723784 | CMS |
| Amgen Inc. | $29.56 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117723786 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.68 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118031268 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.84 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101216914 | CMS |
| GENZYME CORPORATION | $38.67 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139852770 | CMS |
| Novartis Pharmaceuticals Corporation | $19.77 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428840 | CMS |
| Novartis Pharmaceuticals Corporation | $20.69 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428842 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.41 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152274333 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.